Structure-activity relationships for inhibition of cysteine protease activity and development of Plasmodium falciparum by peptidyl vinyl sulfones

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 1, 2003, Pages 154-160

  Shenai, Bhaskar R ^a   Lee, Belinda J ^a   Alvarez Hernandez, Alejandro ^a   Chong, Pek Y ^a   Emal, Cory D ^a   Neitz, R Jeffrey ^a   Roush, William R ^a   Rosenthal, Philip J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; ENZYME INHIBITOR; FALCIPAIN 2; FALCIPAIN 3; PEPTIDYLVINYLSULFONE DERIVATIVE; PHENYLVINYLSULFONE DERIVATIVE; SULFONE DERIVATIVE; UNCLASSIFIED DRUG; VINYL SULFONAMIDE DERIVATIVE; VINYLSULFONATE ESTER DERIVATIVE;

ARTICLE; DRUG ACTIVITY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; NONHUMAN; PARASITE DEVELOPMENT; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

EID: 0037226491     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.1.154-160.2003     Document Type: Article

References (42)

1. Banerjee, R., J. Liu, W. Beatty, L. Pelosof, M. Klemba, and D. E. Goldberg. 2002. Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine. Proc. Natl. Acad Sci. USA 99:990-995.
2. Bold, G., A. Fassler H. G. Capraro, R. Cozens, T. Klimkait, J. Lazdins, J. Mestan, B. Poncioni, J. Rosel, D. Stover, M. Tintelnot-Blomley, F. Acemoglu, W. Beck, E. Boss, M. Eschbach, T. Hurlimann, E. Masso, S. Roussel, K. Ucci-Stoll, D. Wyss, and M. Lang. 1998. New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors: candidates for clinical development. J. Med. Chem. 41:3387-3401.
3. 2 specificity of human cathepsin O2 in comparison with cathepsins S and L. Biochem. J. 315:85-89.
4. Caffrey, C. R., E. Hansell, K. D. Lucas, L. S. Brinen, A. Alvarez-Hernandez, J. Cheng, S. L. Gwaltney II, W. R. Roush, Y. D. Stierhof, M. Bogyo, D. Steverding, and J. H. McKerrow. 2001. Active site mapping, biochemical properties and subcellular localization of rhodesain, the major cysteine protease of Ttypanosoma brucei rhodesiense. Mol. Biochem. Parasitol. 118:61-73.
5. Carretero, J. C., M. Demillequand, and L. Ghosez. 1987. Synthesis of α,β-unsaturated sulphonates via the Wittig-Horner reaction. Tetrahedron 43:5125-5134.
6. Chatterjee, S., M. A. Ator, D. Bozyczko-Coyne, K. Josef, G. Wells, R. Tripathy, M. Iqbal, R. Bihovsky, S. E. Senadhi, S. Mallya, T. M. O'Kane, B. A. McKenna, R. Siman, and J. P. Mallamo. 1997. Synthesis and biological activity of a series of potent fluoromethyl ketone inhibitors of recombinant human calpain I. J. Med. Chem. 40:3820-3828.
7. Cherney, R. J., and L. Wang. 1996. Efficient Mitsunobu reactions with N-phenylfluorenyl or N-trityl serine esters. J. Org. Chem. 61:2544-2546.
8. Edwards, P. D., D. W. Andisik, C. A. Bryant, B. Ewing, B. Gomes, J. J. Lewis, D. Rakiewicz, G. Steelman, A. Strimpler, D. A. Trainor, P. A. Tuthill, R. C. Mauger, C. A. Veale, R. A. Wildonger, J. C. Williams, D. J. Wolanin, and M. Zottola. 1997. Discovery and biological activity of orally active peptidyl trifluoromethyl ketone inhibitors of human neutrophil elastase. J. Med. Chem. 40:1876-1885.
9. Eggleson, K. K., K. L. Duffin, and D. E. Goldberg. 1999. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J. Biol. Chem. 274:32411-32417.
10. Enders, D., S. von Berg, and B. Jandeleit. 2000. Diethyl [(phenylsulfonyl) methyl]phosphonate. Org. Synth. 78:169-175.
11. 1 position. J. Med. Chem. 40:3726-3733.
12. Francis, S. E., D. J. Sullivan, Jr., and D. E. Goldberg. 1997. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol. 51:97-123.
13. Gennari, C., B. Salom, D. Potenza, and A. Williams. 1994. Synthesis of sulfonamido-pseudopeptides - new chiral unnatural oligomers. Angew. Chem. Int. Ed. Engl. 33:2067-2069.
14. Hanzlik, R. P., and S. A. Thompson. 1984. Vinylogous amino acid esters: a new class of inactivators for thiol proteases. J. Med. Chem. 27:711-712.
15. Harris, J. L., B. J. Backes, F. Leonetti, S. Mahrus, J. A. Ellman, and C. S. Craik. 2000. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libraries. Proc. Natl. Acad. Sci. USA 97:7754-7759.
16. Kempf, D. J., H. L. Sham, K. C. Marsh, C. A. Flentge, D. Betebenner, B. E. Green, E. McDonald, S. Vasavanonda, A. Saldivar, N. E. Wideburg, W. M. Kati, L. Ruiz, C. Zhao, L. Fino, J. Patterson, A. Molla, J. J. Plattner, and D. W. Norbeck. 1998. Discovery of ritonavir, a potent inhibitor of HIV protease with high oral bioavailability and clinical efficacy. J. Med. Chem. 41:602-617.
17. Kleinert, H. D., S. H. Rosenberg, W. R. Baker, H. H. Stein, V. Klinghofer, J. Barlow, K. Spina, J. Polakowski, P. Kovar, J, Cohen, and J. Denissen. 1992. Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. Science 257:1940-1943.
18. Lambros, C., and J. P. Vandenberg. 1979. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J. Parasitol. 65:418-420.
19. Liu, S., and R. P. Hanzlik. 1992. Structure-activity relationships for inhibition of papain by peptide Michael acceptors. J. Med. Chem. 35:1067-1075.
20. McKerrow, J. H., E. Sun, P. J. Rosenthal, and J. Bouvier. 1993. The proteases and pathogenicity of parasitic protozoa. Annu. Rev. Microbiol. 47:821-853.
21. Musicki, B., and T. S. Widlanski. 1991. Synthesis of nucleoside sulfonates and sulfones. Tetrahedron Lett. 32:1267-1270.
22. Olson, J. E., G. K. Lee, A. Semenov, and P. J. Rosenthal. 1999. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg. Med. Chem. 7:633-638.
23. Palmer, J. T., D. Rasnick, J. L Klaus, and D. Bromme. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J. Med. Chem. 38:3193-3196.
24. Reynolds, R. C., P. A. Crooks, J. A. Maddry, M. S. Akhtar, J. A. Montgomery, and J. A. Secrist III. 1992. Synthesis of thymidine dimers containing internucleoside sulfonate and sulfonamide linkages. J. Org. Chem. 57:2983-2985.
25. Ridley, R. G. 2002. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 415:686-693.
26. Rosenthal, P. J., J. H. McKerrow, M. Aikawa, H. Nagasawa, and J. H. Leech. 1988. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J. Clin. Investig. 82:1560-1566.
27. Rosenthal, P. J. 2002. Hydrolysis of erythrocyte proteins by proteases of malaria parasites. Curr. Opin. Hematol. 9:140-145.
28. Rosenthal, P. J., and R. G. Nelson. 1992. Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol. Biochem. Parasitol. 51:143-152.
29. Rosenthal, P. J., G. K. Lee, and R. E. Smith. 1993. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J. Clin. Investig. 91:1052-1056.
30. Rosenthal, P. J., J. E. Olson, G. K. Lee, J. T. Palmer, J. L Klaus, and D. Rasnick. 1996. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob. Agents Chemother. 40:1600-1603.
31. Roush, W. R., J. Cheng, B. Knapp-Reed, A. Alvarez-Hernandez, J. H. McKerrow, E. Hansell, and J. C. Engel. 2001. Potent second generation vinyl sulfonamide inhibitors of the trypanosomal cysteine protease cruzain. Bioorg. Med. Chem. Lett. 11:2759-2762.
32. Roush, W. R., S. L. Gwaltney II, J. Cheng, K. A. Scheidt, J. H. McKerrow, and E. Hansell. 1998. Vinyl sulfonate esters and vinyl sulfonamides: potent, irreversible inhibitors of cysteine proteases. J. Am. Chem. Soc. 120:10994-10995.
33. Sachs, J., and P. Malaney. 2002. The economic and social burden of malaria. Nature 415:680-685.
34. Sajid, M., and J. H. McKerrow. 2002. Cysteine proteases of parasitic organisms. Mol. Biochem. Parasitol. 120:1-21.
35. Scheidt, K. A., W. R. Roush, J. H. McKerrow, P. M. Selzer, E. Hansell, and P. J. Rosenthal. 1998. Structure-based design, synthesis and evaluation of conformationally constrained cysteine protease inhibitors. Bioorg. Med. Chem. 6:2477-2494.
36. Serveau, C., G. Lalmanach, M. A. Juliano, J. Scharfstein, L. Juliano, and F. Gauthier. 1996. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. Biochem. J. 313:951-956.
37. Shenai, B. R., and P. J. Rosenthal. 2002. Reducing requirements for hemoglobin hydrolysis by Plasmodium falciparum cysteine proteases. Mol. Biochem. Parasitol. 122:99-104.
38. Shenai, B. R., P. S. Sijwali, A. Singh, and P. J. Rosenthal. 2000. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem. 275:29000-29010.
39. Sijwali, P. S., B. R. Shenai, J. Gut, A. Singh, and P. J. Rosenthal. 2001. Expression and characterization of the Plasmodium falciparum haemoglobinase falcipain-3. Biochem. J. 360:481-489.
40. Smith, A. B., III, R. Hirschmann, A. Pasternak, W. Yao, P. A. Sprengeler, M. K. Holloway, L. C. Kuo, Z. Chen, P. L. Darke, and W. A. Schleif. 1997. An orally bioavailable pyrrolinone inhibitor of HIV-1 protease: computational analysis and X-ray crystal structure of the enzyme complex. J. Med. Chem. 40:2440-2444.
41. Tian, W. X., and C. L. Tsou. 1982. Determination of the rate constant of enzyme modification by measuring the substrate reaction in the presence of the modifier. Biochemistry 21:1028-1032.
42. Veale, C. A., P. R. Bernstein, C. M. Bohnert, F. J. Brown, C. Bryant, J. R. Damewood, Jr., R. Earley, S. W. Feeney, P. D. Edwards, B. Gomes, J. M. Hulsizer, B. J. Kosmider, R. D. Krell, G. Moore, T. W. Salcedo, A. Shaw, D. S. Silberstein, G. B. Steelman, M. Stein, A. Strimpler, R. M. Thomas, E. P. Vacek, J. C. Williams, D. J. Wolanin, and S. Woolson. 1997. Orally active trifluoromethyl ketone inhibitors of human leukocyte elastase. J. Med. Chem. 40:3173-3181.